Soft tissue sarcomas are cancers that develop in your body’s soft tissues like muscle, fat, tendons, or cartilage. Your legs are the most common place they develop. The American Cancer Society ...

Sarcoma originates in connective tissues, with soft tissue and bone sarcomas as primary categories, each having multiple subtypes. Staging considers tumor size, grade, and metastasis, guiding ...

Soft tissue sarcomas are rare—only about 13,500 cases are diagnosed in the United States each year. They arise from what are called mesenchymal cells, which form the connective tissues in the body, ...

A systematic review finds that diagnostic discordance in bone and soft tissue sarcoma may reduce survival, supporting expert second opinions. Phase 2 trial results show anlotinib with anthracyclines ...

Immunotherapy, particularly ICIs, shows potential in treating certain STS subtypes, but efficacy varies and requires further investigation. Blood-based biomarkers, including neutrophil-to-lymphocyte ...

Cancer Patients' and Patient Advocates' Perspectives on a Novel Information Source: A Qualitative Study of The Art of Oncology, When the Tumor Is Not the Target Overall survival at 5 years was 89% in ...

For the last three decades, breakthroughs have been sparse for soft tissue sarcomas, which are rare cancers that affect muscles, fat and other connective tissues. Today, a global team of researchers ...

A novel intratumoral treatment was administered to the first patient in a phase 3 trial for certain patients with metastatic soft tissue sarcoma. A phase 3 trial for patients with metastatic soft ...

A new editorial was published in Volume 16 of Oncotarget on July 16, 2025, titled "microRNAs in soft tissue sarcoma: State of the art and barriers to translation." In this article, Elizaveta K.

Efficacy and Tolerability of a Low-Dose Continuous Regimen of Regorafenib in Refractory Synovial Sarcomas: A Single-Arm, Phase II Trial From India Diagnostic concordance was observed in 296 cases ...